|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 235.00 GBX | -0.84% |
|
+4.68% | +3.98% |
| 11-29 | Devi Shetty Reportedly Sets His Heart on UK's Spire Healthcare | CI |
| 11-29 | FTSE 100 ekes out small gain as New York prospers | AN |
| Capitalization | 954M 1.17B 1.13B 1.06B 1.68B 101B 1.88B 13B 4.83B 41.35B 4.38B 4.29B 181B | P/E ratio 2024 * |
24.1x | P/E ratio 2025 * | 16x |
|---|---|---|---|---|---|
| Enterprise value | 2.12B 2.59B 2.52B 2.36B 3.73B 225B 4.17B 28.91B 10.74B 91.92B 9.73B 9.53B 403B | EV / Sales 2024 * |
1.39x | EV / Sales 2025 * | 1.28x |
| Free-Float |
65.28% | Yield 2024 * |
1.18% | Yield 2025 * | 1.65% |
More valuation ratios
* Estimated data
More news
Last Transcript: Spire Healthcare Group plc
More recommendations
More press releases
More news
| 1 week | +5.57% | ||
| Current month | +4.87% | ||
| 1 month | +5.10% | ||
| 3 months | +4.87% | ||
| 6 months | -2.27% | ||
| Current year | +4.87% |
1 week
223.40
239.19
1 month
219.13239.19
Current year
221.00239.19
1 year
212.50270.50
3 years
201.00270.50
5 years
51.10270.50
10 years
51.10411.00
| Director | Title | Age | Since |
|---|---|---|---|
Justinian Ash
CEO | Chief Executive Officer | 60 | 29/10/2017 |
Harbant Samra
DFI | Director of Finance/CFO | - | 08/05/2024 |
Lisa Grant
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/2023 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dame Husband
BRD | Director/Board Member | - | 31/05/2014 |
Justinian Ash
BRD | Director/Board Member | 60 | 29/10/2017 |
C. van der Merwe
BRD | Director/Board Member | 61 | 23/05/2018 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +5.57% | +6.28% | -5.01% | 1.17B | ||
| -0.32% | +1.30% | -13.77% | -40.64% | 15.8B | ||
| +0.56% | +1.27% | +19.17% | +8.99% | 13.92B | ||
| +0.57% | -2.97% | +15.22% | +39.02% | 11.27B | ||
| 0.00% | +0.42% | -15.00% | +6.73% | 10.95B | ||
| +0.85% | +1.69% | +32.13% | +43.35% | 9.51B | ||
| +1.30% | +2.37% | +16.87% | +69.50% | 7.76B | ||
| -2.85% | -6.21% | +53.91% | +122.70% | 5.78B | ||
| -0.06% | +1.21% | -31.27% | -49.27% | 4.87B | ||
| +0.88% | +3.85% | -24.38% | -3.97% | 4.89B | ||
| Average | +0.09% | +0.40% | +5.92% | +19.14% | 8.59B | |
| Weighted average by Cap. | +0.17% | +0.42% | +6.29% | +16.20% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1.53B 1.87B 1.81B 1.7B 2.69B 162B 3B 20.8B 7.73B 66.14B 7B 6.86B 290B | 1.62B 1.98B 1.92B 1.81B 2.85B 172B 3.19B 22.08B 8.21B 70.21B 7.43B 7.28B 308B |
| Net income | 39.98M 48.91M 47.51M 44.57M 70.41M 4.24B 78.64M 545M 203M 1.73B 184M 180M 7.6B | 60.7M 74.26M 72.14M 67.67M 107M 6.43B 119M 827M 308M 2.63B 279M 273M 11.53B |
| Net Debt | 1.17B 1.43B 1.39B 1.3B 2.05B 124B 2.29B 15.9B 5.91B 50.57B 5.35B 5.24B 222B | 1.12B 1.37B 1.33B 1.24B 1.97B 118B 2.19B 15.21B 5.65B 48.37B 5.12B 5.01B 212B |
More financial data
* Estimated data
Employees
12,787
Calendar
26/02/2025
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/01/25 | 235.00 p | -0.84% | 492,693 |
| 16/01/25 | 237.00 p | 0.00% | 503,606 |
| 15/01/25 | 237.00 p | +3.95% | 447,883 |
| 14/01/25 | 228.00 p | +0.88% | 654,923 |
| 13/01/25 | 226.00 p | +0.67% | 366,570 |
Delayed Quote London S.E., January 17, 2025 at 11:20 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.370GBP
Average target price
3.074GBP
Spread / Average Target
+29.69%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SPI Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition